Suven Life Sciences (BOM:530239) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530239 Suven Life Sciences Ltd BOM:530239
40 GF Score
Price ₹342.55
GF Value ₹123.76
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Suven Life Sciences Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:530239
40GF Score
Suven Life Sciences Ltd BOM:530239
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Suven Life Sciences (BOM:530239) Overvalued in 2026?

Based on GuruFocus' analysis, Suven Life Sciences stock appears to be overvalued. The current stock price of ₹342.55 is trading 176.8% above its estimated GF Value™ of ₹123.76. GuruFocus considers Suven Life Sciences to be Significantly Overvalued.

Key valuation signals for BOM:530239:

  • Short Ratio:
  • GF Value™: ₹123.76 vs. price of ₹342.55 (176.8% above fair value)
  • GF Score™: 40/100 with 9 warning signs

No single metric tells the full story. See the BOM:530239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suven Life Sciences Business Description

Other Exchanges SUVEN:India
Address Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, Hyderabad, TG, IND, 500 034
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.
40GF Score

Get the complete analysis for BOM:530239

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹342.55
Price
₹123.76
GF Value